Cite
HARVARD Citation
Mohamed, M. et al. (n.d.). AB0478 Mild and moderate hepatic impairment have no clinically relevant impact on upadacitinib pharmacokinetics: results from a dedicated phase 1 study. Annals of the rheumatic diseases. p. 1400. [Online].